Time to hit pause on mitochondria-targeting cancer therapies
X Zhang, CV Dang - Nature medicine, 2023 - nature.com
X Zhang, CV Dang
Nature medicine, 2023•nature.comTime to hit pause on mitochondria-targeting cancer therapies | Nature Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with
limited support for CSS. To obtain the best experience, we recommend you use a more up
to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement Nature Medicine View all journals Search My Account Explore content About …
main content Thank you for visiting nature.com. You are using a browser version with
limited support for CSS. To obtain the best experience, we recommend you use a more up
to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement Nature Medicine View all journals Search My Account Explore content About …
As another clinical trial of a mitochondria-targeting cancer therapy faces failure, it calls for a thorough re-evaluation of the strategy; the time has come to go from the bedside back to the bench.
nature.com